XSHE
002772
Market cap596mUSD
Oct 09, Last price
10.94CNY
1D
2.63%
1Q
-13.99%
Jan 2017
-46.82%
IPO
8.99%
Name
Tianshui Zhongxing Bio-technology Co Ltd
Chart & performance
P/E
12.24
P/S
1.95
EPS
0.89
Div yield, %
2.81%
Shrs. gr., 5y
-0.87%
Rev. gr., 5y
6.16%
Revenues
2.10b
+8.43%
Net income
335m
+161.63%
CFO
504m
+1.82%
Dividend
Oct 14, 20260.15 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Tianshui Zhongxing Bio-technology Co.,Ltd. is a Chinese enterprise dedicated to the research, development, cultivation, and distribution of edible fungi throughout the country. Its product line features various mushroom offerings, marketed under prominent brands such as Xi Huang, Nüwa, and Zhongxing. The company, which established its operations in 2005 and is headquartered in Tianshui, China, officially adopted its current name, Tianshui Zhongxing Bio-technology Co.,Ltd., in March 2012, having previously been known as Tianshui Zhongxing Bio-technology Ltd.
Key people
Boshu Gao
Chairman of the Board · since 2021
Min Li
Chief Financial Officer · since 2024
Shoufu Zhang
Deputy General Manager · since 2024
Jinjun Zhou
Deputy General Manager
Xiaoli Qian
Secretary of the Board · since 2021
Liang Liu
General Manager, Director · since 2018
Xiaojun Shao
Director · since 2024
Chunhui Tao
Vice Chairman of the Board, Deputy General Manager · since 2021
Guoqing Wang
Director · since 2021
Boyu Yao
Director · since 2021
Lin Dang
Independent Director · since 2021
Ping Jia
Independent Director · since 2024
Guigen Qiu
Independent Director · since 2024
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||